Roche Confirms Profit Forecast as Sales Beat Estimates
Roche confirmed its profit outlook for the year after its eye drug Vabysmo, multiple-sclerosis treatment Ocrevus and hemophilia injection Hemlibra lifted third-quarter sales above analysts’ expectations. Continue reading View comments